Troy H Puar
Overview
Explore the profile of Troy H Puar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, et al.
Lancet Diabetes Endocrinol
. 2025 Jan;
13(2):119-133.
PMID: 39824204
Background: Primary aldosteronism can be treated medically but there is no standardised method to evaluate treatment outcomes. We aimed to develop criteria for assessing the outcomes of targeted medical treatment...
2.
Sukor N, Sunthornyothin S, Tran T, Tarigan T, Mercado-Asis L, Sum S, et al.
J Clin Endocrinol Metab
. 2024 Jan;
109(7):1718-1725.
PMID: 38261997
Context: While guidelines have been formulated for the management of primary aldosteronism (PA), following these recommendations may be challenging in developing countries with limited health care access. Objective: We aimed...
3.
Gupta G, Teo A, Swee D, Loh L, Chuah M, Loh W, et al.
J Clin Endocrinol Metab
. 2023 Dec;
109(8):e1574-e1581.
PMID: 38134306
Context: Primary aldosteronism (PA) is a common cause of hypertension (HT). However, diagnosis is often delayed, leading to poorer clinical outcomes. Hypokalemia with HT is characteristic of PA, and is...
4.
King T, Mok Y, Dacay L, Wong H, Hsu P, Tan A, et al.
J Clin Endocrinol Metab
. 2023 Sep;
109(3):844-851.
PMID: 37721483
Context: Obstructive sleep apnea (OSA) is associated with increased nocturnal sympathetic activity. In OSA patients, elevations in metanephrines may lead to false-positive tests when evaluating for pheochromocytoma or paraganglioma (PPGL)....
5.
Sukor N, Puar T, Sunthornyothin S, Kamaruddin N
Front Endocrinol (Lausanne)
. 2023 May;
14:1171857.
PMID: 37143727
No abstract available.
6.
Seah S, Tan Y, Teh K, Loh W, Tan P, Goh L, et al.
Front Pharmacol
. 2023 Feb;
14:1092476.
PMID: 36794273
Long-term proton pump inhibitor (PPI) use has been associated with hypomagnesemia. It is unknown how frequently PPI use is implicated in patients with severe hypomagnesemia, and its clinical course or...
7.
Puar T, Cheong C, Foo R, Saffari S, Tu T, Chee M, et al.
Front Endocrinol (Lausanne)
. 2022 Jul;
13:916744.
PMID: 35846272
Introduction: Primary aldosteronism (PA) is associated with increased risk of cardiovascular events. However, treatment of PA has not been shown to improve left ventricular (LV) systolic function using the conventional...
8.
Puar T, Khoo C, Tan C, Tong A, Tan M, Teo A, et al.
J Hypertens
. 2022 Jun;
40(6):1179-1188.
PMID: 35703880
Objective: Adrenal vein sampling (AVS) is recommended to subtype primary aldosteronism, but it is technically challenging. We compared 11C-Metomidate-PET-computed tomography (PET-CT) and AVS for subtyping of primary aldosteronism. Methods: Patients...
9.
Tan S, Xiong J, Puar T, Khoo J, Wong A, Soh S
Case Rep Med
. 2022 May;
2022:5827664.
PMID: 35531575
A previously well 32-year-old Chinese male presented with acute bilateral upper and lower limb paralysis upon waking, ten days after the onset of COVID-19 infection. Examination revealed areflexia over all...
10.
Nguyen V, Tu T, Mamauag M, Lai J, Saffari S, Aw T, et al.
Front Endocrinol (Lausanne)
. 2022 May;
13:869980.
PMID: 35518929
Background: Primary aldosteronism (PA) is the most common cause of secondary hypertension, and patients are at an increased risk of atrial fibrillation (AF) and stroke. We assessed the prevalence of...